TransDetect® PCR Mycoplasma Detection Kit - FM311
Product Name
TransDetect® PCR Mycoplasma Detection Kit(FM311)
High-Impact Factor Literature Collection
•Lei Z, Meng H, Liu L, et al. Mitochondrial base editor induces substantial nuclear off-target mutations[J]. Nature, 2022.(IF 69.50)
•Huang J, Lin Q, Fei H, et al. Discovery of deaminase functions by structure-based protein clustering[J]. Cell, 2023.(IF 65.00)
•Liu J L, Yan X Q, Wu H, et al. RNA codon expansion via programmable pseudouridine editing and decoding[J]. Nature, 2025.(IF 50.50)
•Xu D, Zhao H, Jin M, et al. Modulating TRADD to restore cellular homeostasis and inhibit apoptosis[J]. Nature, 2020.(IF 42.78)
•Fei H Y, LI Y J, Liu Y J, et al. Advancing protein evolution with inverse folding models integrating structural and evolutionary constraints[J]. Cell, 2025.(IF 42.50)
•Sun C, Li H C, Liu Y J, et al. Iterative recombinase technologies for efficient and precise genome engineering across kilobase to megabase scales[J]. Cell, 2025.(IF 42.50)
•Bai X, Sun P, Wang X, et al. Structure and dynamics of the EGFR/HER2 heterodimer[J]. Cell Discovery, 2023.(IF 38.07)
•Wang D, Li X, Jiao D, et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia[J]. Journal of Hematology & Oncology, 2023.(IF 28.50)
•Nian Z, Dou Y, Shen Y, et al. Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation[J]. Immunity.2024.(IF 25.50)
•Li Z, Wang Z, Zhong C, et al. P53 upregulation by USP7-engaging molecular glues[J]. Science Bulletin, 2024.(IF 18.80)
•Xu J, Liang Y, Li N, et al. Clathrin-associated carriers enable recycling through a kiss-and-run mechanism[J]. Nature Cell Biology, 2024. (IF 17.30)
•Fan S, Qi M, Qi Q, et al. Targeting FAPα-positive lymph node metastatic tumor cells suppresses colorectal cancer metastasis[J]. Acta Pharmaceutica Sinica B, 2024.(IF 14.80)
•Wang J, An Z, Wu Z, et al. Spatial organization of PI3K-PI (3, 4, 5) P3-AKT signaling by focal adhesions[J]. Molecular Cell, 2024.(IF 14.50)
•Zhang W, Yin C, Qi L, et al. RFWD3 reprograms nucleotide metabolism through PHGDH to induce chemoresistance in osteosarcoma[J]. Advanced Science, 2025.(IF 14.10)
•Nian Z, Zheng X, Dou Y, et al. Rapamycin pretreatment rescues the bone marrow AML cell elimination capacity of CAR-T cells[J]. Clinical Cancer Research, 2021.(IF 12.50)
•Wang L, Wang Y, He X, et al. CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells[J]. Cell Reports Medicine, 2025.(IF 10.60)
•Gu Y, Wei X, Sun Y, et al. miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features[J]. Cancer research, 2019.(IF 8.38)
•Liu Z, Chen Z, Wang J, et al. Mouse avatar models of esophageal squamous cell carcinoma proved the potential for EGFR-TKI afatinib and uncovered Src family kinases involved in acquired resistance[J]. Journal of Hematology & Oncology, 2018.(IF 7.33)
•Lu B, Dong L, Yi D, et al. Transposase-assisted tagmentation of RNA/DNA hybrid duplexes[J]. Elife, 2020.(IF 7.08)
Features
•High Sensitivity: An optimized, highly sensitive detection system minimizes the risk of false negatives.
•Comprehensive Coverage: Designed with multiple specific primers targeting the mycoplasma 16S rRNA sequence, it comprehensively covers 54 mycoplasma species, including common laboratory contaminants.
•Simple & Fast: Requires no complex sample preparation, with an amplification time of 65 minutes—30 minutes faster than the V1 version.
•Excellent Stability: Tolerates a 5 μl volume of various sample types and demonstrates high thermal acceleration stability.
•High Specificity: No cross-amplification with common bacteria or engineered cell lines, ensuring reliable results.
Data Presentation
Broad detection range
Testing of seven common mycoplasma standards showed that the TransGen product detected all of them, while Company G's product demonstrated weaker amplification.
High Sensitivity
When testing a 100 copies/μl mycoplasma standard, the TransGen product demonstrated a detection sensitivity of 100 copies/μl. The Company G product failed to detect it.
High Inhibitor Tolerance
When amplifying 1-5 μl of mycoplasma-positive cell culture supernatant, the TransGen product exhibited excellent tolerance to inhibitors, maintaining robust performance even at the maximum 5 μl loading volume.
Detects 54 Mycoplasma Species
Product Information
